|
Name |
7-methoxy-13-dehydroxypaxilline
|
| Molecular Formula | C28H35NO4 | |
| IUPAC Name* |
7-(2-hydroxypropan-2-yl)-5-methoxy-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.02,11.05,10.016,24.017,22]tetracosa-9,16(24),17,19,21-pentaen-8-one
|
|
| SMILES |
COC12CCC3(C)C(CCC4Cc5c([nH]c6ccccc56)C43C)C1=CC(=O)C(C(C)(C)O)O2
|
|
| InChI |
InChI=1S/C28H35NO4/c1-25(2,31)24-22(30)15-20-19-11-10-16-14-18-17-8-6-7-9-21(17)29-23(18)27(16,4)26(19,3)12-13-28(20,32-5)33-24/h6-9,15-16,19,24,29,31H,10-14H2,1-5H3/t16-,19-,24-,26-,27+,28-/m0/s1
|
|
| InChIKey |
KGRLALMEBDDCIJ-FNIFYGCESA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 449.59 | ALogp: | 4.8 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 71.6 | Aromatic Rings: | 6 |
| Heavy Atoms: | 33 | QED Weighted: | 0.66 |
| Caco-2 Permeability: | -4.773 | MDCK Permeability: | 0.00001840 |
| Pgp-inhibitor: | 0.997 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.004 |
| 30% Bioavailability (F30%): | 0.346 |
| Blood-Brain-Barrier Penetration (BBB): | 0.593 | Plasma Protein Binding (PPB): | 95.51% |
| Volume Distribution (VD): | 2.308 | Fu: | 1.60% |
| CYP1A2-inhibitor: | 0.035 | CYP1A2-substrate: | 0.952 |
| CYP2C19-inhibitor: | 0.239 | CYP2C19-substrate: | 0.953 |
| CYP2C9-inhibitor: | 0.436 | CYP2C9-substrate: | 0.46 |
| CYP2D6-inhibitor: | 0.062 | CYP2D6-substrate: | 0.449 |
| CYP3A4-inhibitor: | 0.843 | CYP3A4-substrate: | 0.931 |
| Clearance (CL): | 11.262 | Half-life (T1/2): | 0.116 |
| hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.216 |
| Drug-inuced Liver Injury (DILI): | 0.53 | AMES Toxicity: | 0.925 |
| Rat Oral Acute Toxicity: | 0.929 | Maximum Recommended Daily Dose: | 0.273 |
| Skin Sensitization: | 0.128 | Carcinogencity: | 0.708 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.027 |
| Respiratory Toxicity: | 0.978 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005990 | ![]() |
0.828 | D0U7GP | ![]() |
0.295 | ||
| ENC002279 | ![]() |
0.705 | D0H4JM | ![]() |
0.295 | ||
| ENC000836 | ![]() |
0.661 | D01JGV | ![]() |
0.295 | ||
| ENC001492 | ![]() |
0.602 | D05MQK | ![]() |
0.257 | ||
| ENC003876 | ![]() |
0.596 | D0H2JP | ![]() |
0.257 | ||
| ENC002951 | ![]() |
0.595 | D06AWE | ![]() |
0.257 | ||
| ENC005405 | ![]() |
0.585 | D0K0KH | ![]() |
0.254 | ||
| ENC003172 | ![]() |
0.584 | D0OT9S | ![]() |
0.249 | ||
| ENC005989 | ![]() |
0.584 | D04RLY | ![]() |
0.249 | ||
| ENC005406 | ![]() |
0.570 | D09HDR | ![]() |
0.249 | ||